Rhea-AI Summary
Acutus Medical, Inc. amendment to a Schedule 13G/A reports updated beneficial ownership disclosures by Advent Life Sciences LLP, Advent Life Sciences Fund I LP and Dr. Shahzad Malik.
The filing states Advent Life Sciences LLP and Advent Life Sciences Fund I LP each hold 0 shares. Dr. Shahzad Malik holds 3,281 restricted shares of common stock and options to purchase 19,476 shares, representing 0.07608% of the class. The reporting persons disclaim beneficial ownership except to the extent of any pecuniary interest. Signatures are dated 02/13/2026.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
FAQ
How many Acutus Medical (AFIB) SEC filings are available on StockTitan?
StockTitan tracks 1 SEC filings for Acutus Medical (AFIB). Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for Acutus Medical (AFIB)?
The most recent SEC filing for Acutus Medical (AFIB) was filed on February 17, 2026.